Hostname: page-component-586b7cd67f-rcrh6 Total loading time: 0 Render date: 2024-11-26T22:01:29.494Z Has data issue: false hasContentIssue false
  • English
  • Français

Drugs for Alzheimer's disease

Published online by Cambridge University Press:  02 January 2018

Andrew W. Procter
Andrew W. Procter*
Affiliation:
United Medical and Dental Schools, Guy's Hospital Campus, London SE1 9RT
Rights & Permissions [Opens in a new window]

Extract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

The view (Anon, 1990) that “drugs for Alzheimer's Disease (AD) are generally ineffective” is a reasonable conclusion to draw from the results of treatment studies to date. However in recent years there has been a rapid expansion of knowledge of both basic neurobiology and the pathology of AD. Future advances may be expected to arise from this, so when the authors of Drugs and Therapeutics Bulletin next review this subject they may well be able to draw a more optimistic conclusion.

Type
Expert Opinion
Information
Psychiatric Bulletin , Volume 14 , Issue 11 , November 1990 , pp. 676
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
Copyright © Royal College of Psychiatrists, 1990

References

Anon (1990) Drugs for Alzheimer's disease. Drugs and Therapeutics Bulletin, 28, 42–44.CrossRefGoogle Scholar
Bowen, D. M. (1990) Treatment of Alzheimer's disease, molecular pathology versus neurotransmitter-based therapy. British Journal of Psychiatry, 157, 327–330.CrossRefGoogle ScholarPubMed
Fairburn, C. G. & Hope, R. A. (1988) Changes in behaviour in dementia: a neglected research area. British Journal of Psychiatry, 152, 406–407.CrossRefGoogle ScholarPubMed
Greenamyre, J. T. & Young, A. B. (1989) Excitatory amino acids and Alzheimer's disease. Neurobiology of Aging, 10, 593–602.Google Scholar
McEntee, W. J. & Crook, T. H. (1990) Age-associated memory impairment: a role for catecholamines. Neurology, 40, 526–530.CrossRefGoogle ScholarPubMed
Palmer, A. M., Stratmann, G. C., Procter, A. W. & Bowen, D. M. (1988) Possible neurotransmitter basis of behavioural changes in Alzheimer's disease. Annals of Neurology, 23, 616–620.CrossRefGoogle ScholarPubMed
Whalley, L. J. (1989) Drug treatments of dementia. British Journal of Psychiatry, 155, 595–611.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.